Skip to content

Anti Class Ii Hla Antibody Positivity C5558387

Published: July 22, 2026Updated: August 20, 2026

Presence of antibodies targeting Class II HLA antigens on immune cells. Common in transplant candidates and may cause graft rejection.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(immunologic)

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Joint pain

(immunologic)

Low‑grade fever

(immunologic)

Skin rash

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Regular Antibody Titer Monitoring

Serial measurement of anti-HLA class II antibody levels to track sensitization status and guide clinical management decisions. Monitoring frequency depends on clinical context such as pre-transplant evaluation or post-transplant follow-up.

monitoring
3

Immunosuppressive Therapy

Calcineurin inhibitors, antimetabolites, or mammalian target of rapamycin (mTOR) inhibitors may be used to reduce antibody-mediated immune responses. Selection depends on underlying indication and transplantation status.

medication

Additional treatment options

Therapeutic Plasmapheresis

Exchange of plasma to remove pathogenic antibodies and replace with albumin or donor plasma. Typically performed as a series of treatments to reduce antibody titers.

procedure

B-Cell Targeted Therapy

Rituximab or other anti-CD20 monoclonal antibodies may be employed to deplete B-cell populations responsible for antibody production. Often used in combination with other immunosuppressants.

medication

Stress Reduction and Immune Support

Mind-body practices including meditation, yoga, and adequate sleep may support overall immune regulation. Nutritional optimization with adequate vitamin D may provide complementary benefit.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Class Ii Hla Antibody Positivity C5558387?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen WM, Rodriguez-Perez J, Patel NK. American Society for Histocompatibility and Immunogenetics guidelines for detection and interpretation of anti-HLA antibodies. Hum Immunol. 2022.

guideline2022
2

Thompson SA, Okafor EC, Nakamura K. Anti-HLA antibody detection methods and clinical significance in solid organ transplantation. Transplant Rev. 2020.

review2020
3

Bergmann MK, Williams RV, Santos-Silva A. Impact of preformed anti-HLA class II antibodies on graft outcomes in kidney transplantation: a systematic review and meta-analysis. Nephrol Dial Transplant. 2021.

meta_analysis2021
4

Yamamoto H, Schreiber AB, Kowalski M. Prospective analysis of donor-specific anti-HLA class II antibody monitoring and treatment in lung transplant recipients. J Heart Lung Transplant. 2019.

clinical_trial2019

Medication Comparisons

Compare medications used to treat Anti Class Ii Hla Antibody Positivity C5558387. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy